BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/17/2021 8:56:01 AM | Browse: 335 | Download: 481
 |
Received |
|
2021-03-22 15:37 |
|
Peer-Review Started |
|
2021-03-22 15:40 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-06-14 03:13 |
|
Revised |
|
2021-07-12 22:37 |
|
Second Decision |
|
2021-12-07 03:16 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-12-08 05:56 |
|
Articles in Press |
|
2021-12-08 05:56 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-10-28 03:35 |
|
Typeset the Manuscript |
|
2021-12-15 02:17 |
|
Publish the Manuscript Online |
|
2021-12-17 08:56 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Frontier |
| Article Title |
Orphan patients with inflammatory bowel disease - when we treat beyond evidence
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Giuseppe Privitera, Daniela Pugliese, Loris Riccardo Lopetuso, Franco Scaldaferri, Alfredo Papa, Gian Lodovico Rapaccini, Antonio Gasbarrini and Alessandro Armuzzi |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Alessandro Armuzzi, MD, PhD, Professor, Dipartimento Universitario di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, NA, Rome 00168, Italy. alearmuzzi@yahoo.com |
| Key Words |
Pouchitis; Proctitis; Stoma; Short-bowel; Ileo-rectal anastomosis; Biologics |
| Core Tip |
Inflammatory bowel disease (IBD) patients with chronic refractory pouchitis, refractory ulcerative proctitis (including those with ileorectal anastomosis), stomas, or short-bowel are routinely excluded from clinical trials, and there is a consequent lack of quality data with regard to their management; however, these patients represent a part of IBD real-life population that needs to be acknowledged. In the present article, our aim is therefore to outline the evidence available so far, and to highlight the main knowledge gaps still present. |
| Publish Date |
2021-12-17 08:56 |
| Citation |
Privitera G, Pugliese D, Lopetuso LR, Scaldaferri F, Papa A, Rapaccini GL, Gasbarrini A, Armuzzi A. Orphan patients with inflammatory bowel disease - when we treat beyond evidence. World J Gastroenterol 2021; 27(47): 8047-8057 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i47/8047.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i47.8047 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
